Model
Edge
Ascendis Pharma
ASND
Filing Type
20-F
Filing Date
3/1/2022
Updated
3/2/22, 9:20 AM
Filing
20-F
Earnings Release
Exhibits
20-F
Annual and Transition Report of Foreign Private Issuers
EX-2.3
EX-2.3
EX-4.16
EX-4.16
EX-4.17
EX-4.17
EX-4.18
EX-4.18
EX-12.1
EX-12.1
EX-12.2
EX-12.2
EX-13.1
EX-13.1
EX-13.2
EX-13.2
EX-15.1
EX-15.1
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic